Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06619496 · ClinicalTrials.gov registry record · NA
Health in Motion Pragmatic Clinical Trial - WRAPAROUND
A NA study, sponsored by Blue Marble Rehab.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT06619496: Completed NA study, sponsored by Blue Marble Rehab.
NCT06619496 is a NA study that has completed, run by Blue Marble Rehab. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06619496, a NA study, has completed, sponsored by Blue Marble Rehab.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
Falls among older adults are a serious public health concern, and injuries resulting from falls can cause significant loss of independence, premature death, and higher caregiver burden. Home-based fall prevention programs, such as the Otago Exercise Program, educate older adults about the importance of identifying fall risk and provide strategies for reducing fall risk; however, many are costly and are not scalable, accessible, or sustainable. This project will compare a digital fall prevention program used in a group setting in the community with traditional community-based fall prevention programs.
Primary Outcome
number of falls during the intervention compared with the self-reported falls at baseline
Interventions
- BEHAVIORAL Human-led fall prevention program
- BEHAVIORAL Avatar-led fall prevention program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What the finished NCT06619496 record still lists
NCT06619496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Human-led fall prevention program is the first listed.
NCT06619496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06619496 about?
NCT06619496 is a clinical study titled "Health in Motion Pragmatic Clinical Trial - WRAPAROUND". Falls among older adults are a serious public health concern, and injuries resulting from falls can cause significant loss of independence, premature death, and higher caregiver burden. Home-based fall prevention programs, such as the Otago Exercise Program, educate older adults about the importance...
What is the current status of trial NCT06619496?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2022-10-24. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT06619496?
The interventions under investigation include: Human-led fall prevention program (BEHAVIORAL), Avatar-led fall prevention program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06619496?
This trial is sponsored by Blue Marble Rehab, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06619496's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI